FDA Warning Letter — Eli Lilly & Company

Case 716462 — FEI 1819470

The FDA took a Warning Letter action against Eli Lilly & Company on September 9, 2025 (Indianapolis, IN). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
Eli Lilly & Company
Date
September 9, 2025
Fiscal Year
2025
Product Type
Drugs
Center
CDER
Location
Indianapolis, IN (United States)